134
Views
7
CrossRef citations to date
0
Altmetric
Article

Novel Praziquantel Treatment Regime for Controlling Asian Tapeworm Infections in Pond-Reared Fish

, &
Pages 113-117 | Received 29 Nov 2010, Accepted 09 Jun 2011, Published online: 08 Feb 2012
 

Abstract

The Asian tapeworm Bothriocephalus achelognathii is an intestinal fish parasite that is nonnative to but widespread throughout the southwestern United States. Praziquantel is an anthelminthic drug commonly used to treat fish for Asian tapeworm; however, it does not kill tapeworm eggs, so the water in ponds used for fish rearing must be exchanged after treatment. Our objective was to determine whether a system containing both an intermediate copepod host and a definitive fish host for Asian tapeworm could be treated without exchanging the water by using a follow-up treatment for any tapeworms that developed from eggs released before or during the first treatment. Here, we have described a new praziquantel treatment regimen to control Asian tapeworm infections in freshwater-reared fish. To evaluate the efficacy of this regimen, we stocked 50 red shiners Cyprinella lutrensis and an intermediate copepod host, Cyclops vernalis, into each of six pond mesocosms containing artificial macrophytes, sand, and gravel to simulate natural pools and provide suitable substrate for the copepod's life history. The test fish population had been naturally infected with B. achelognathii and had an initial infection prevalence of 14% and an infection intensity of 2.14 ± 2.19 (mean ± SD) worms per fish. Three mesocosms were treated twice, each with 2.5 mg/L praziquantel; 19 d passed between treatments to allow for possible reinfection to occur. After a 2.5-month posttreatment period to allow any remaining tapeworms to reestablish themselves, we killed and dissected all of the remaining fish. No worms were found in treated fish; however, the control group had an infection prevalence of 18 ± 6% and an infection intensity of 3.45 ± 2.1 worms per fish. Based on these results, we concluded that the praziquantel treatment regime administered was efficacious and suggest testing it on a larger scale. We caution that praziquantel has not been approved by the U.S. Food and Drug Administration for use on fish but can be used legally in some situations.

Received November 29, 2010; accepted June 9, 2011

ACKNOWLEDGMENTS

This experiment was one component of a larger project funded by the Arizona Game and Fish Department Heritage Program, the National Fish and Wildlife Foundation, the U.S. Fish and Wildlife Service, the U.S. National Park Service, and the U.S. Geological Survey. We thank Andrea Francis for care of the fish and copepods used in this experiment and managing the day-to-day laboratory and greenhouse operations. We also thank Debra Hughson of the National Park Service; Robyn Beck, James deVos, and Chantal O’Brien of the Arizona Game and Fish Department; Charles Ault and William Radke of the U.S. Fish and Wildlife Service for project oversight; William J. Matter, Colleen Caldwell, David Ward, and two anonymous referees for reviews. Mention of trade names or commercial products does not constitute endorsement or recommendation for use by the U.S. Government.

Log in via your institution

Log in to Taylor & Francis Online

There are no offers available at the current time.

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.